2 research outputs found
Additional file 1: Table S1. of Characteristics and risk factors for 28-day mortality of hospital acquired fungemias in ICUs: data from the EUROBACT study
Baseline characteristics of patients with fungemia. Table S2 Characteristics of fungemia episodes at diagnosis. (DOCX 19 kb
Additional file 1 of Safety, efficacy, and pharmacokinetics of gremubamab (MEDI3902), an anti-Pseudomonas aeruginosa bispecific human monoclonal antibody, in P. aeruginosa-colonised, mechanically ventilated intensive care unit patients: a randomised controlled trial
Additional file 1: Supplementary Methods, Results, Tables and Figures